BIOMAT Database Logo BIOMAT Database Logo

Abnormal polyamine metabolism in hypertensive cardiac hypertrophy. 1988

M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Third Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

In order to assess myocardial hypertrophic activity during the process of hypertensive cardiac hypertrophy in the presence and absence of treatment with anti-hypertensive agents, we analyzed myocardial polyamine concentrations in spontaneous hypertensive (SHR) rats and control rats of Wistar Kyoto (WKY) strain. The anti-hypertensive agents studied were diltiazem, hydralazine and captopril, each of which was administered for 5 weeks. In comparison with WKY rats, SHR rats showed elevated blood pressure and enlarged hearts with higher myocardial spermidine concentration. Although blood pressure was lowered in the diltiazem-treated SHR rats, heart weight and myocardial spermidine concentration increased as in untreated SHR rats. In the hydralazine-treated group increases in both blood pressure and myocardial spermidine concentration were suppressed, while an increase in heart weight was not. In the captopril-treated group, increases in blood pressure, heart weight and spermidine concentration were all suppressed. Since spermidine level appears to be a sensitive indicator of hypertrophic activity in the heart, this study suggests that captopril exerts an inhibitory effect on hypertensive cardiac hypertrophy whereas diltiazem does not. It also suggests that hypertrophy may reach a certain plateau level earlier in the hydralazine-treated animals than in others.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D009955 Ornithine Decarboxylase A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. Ornithine Carboxy-lyase,Carboxy-lyase, Ornithine,Decarboxylase, Ornithine,Ornithine Carboxy lyase
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Polyamine metabolism during cardiac hypertrophy.
November 1980, The American journal of physiology,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Polyamine metabolism in myocardial hypertrophy.
April 1982, European heart journal,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Cardiac polyamine metabolism in spontaneously hypertensive rats: effect of antihypertensive treatment.
December 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Altered cardiac polyamine biosynthesis in spontaneously hypertensive rats.
August 1987, The American journal of physiology,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Cardiac hypertrophy in spontaneously hypertensive rats.
March 1975, Japanese heart journal,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Cardiac hypertrophy in spontaneously hypertensive rats.
November 1974, Circulation research,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Cardiac hypertrophy in genetically hypertensive rats.
October 1960, The Journal of pathology and bacteriology,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Proceedings: Cardiac metabolism in hypertrophy.
June 1973, Acta cardiologica,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency.
January 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
M Shimizu, and I Masuda, and K Aihara, and T Nakano, and K Ogawa, and T Mizokami, and O Irimajiri, and I Taniguchi, and H Ozasa, and S Kageyama
Factors influencing cardiac hypertrophy in hypertensive patients.
December 1981, Clinical science (London, England : 1979),
Copied contents to your clipboard!